Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review.
Khalid A AlshehriYousuf AlqurashiMazin MerdadShaza SamargandyRazan DaghistaniHani MarzoukiPublished in: Cancer reports (Hoboken, N.J.) (2021)
Lenvatinib is a feasible option in patients with inoperable TC and can stabilize the lesion size or even reduce it, leading to a more favorable surgical outcome.